Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Vinorelbine in Recurrent or Refractory Hodgkin's Lymphoma
NCT00070304Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- Jul 2004
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 2, open-label, single-arm trial of gemcitabine and vinorelbine in Hodgkin lymphoma (HL), sponsored by Children's Oncology Group. Primary endpoint: Tumor Response Rate at 1 year. Started Jul 2004; status: completed.
02
Drugs
gemcitabinevinorelbine
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00070304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00070304.